Davide Tinti
Overview
Explore the profile of Davide Tinti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trada M, Novara C, Moretto M, Burzi E, Tinti D, de Sanctis L
Children (Basel)
. 2025 Feb;
12(2).
PMID: 40003320
Background: Neonatal diabetes (NDM) is a rare genetic disorder diagnosed in infants under six months of age, characterized by persistent hyperglycemia resulting from insufficient or absent insulin production. Unlike the...
2.
Tinti D, Nobili C, Baretta I, Rosso A, Trada M, de Sanctis L
Diabetes Obes Metab
. 2024 Jun;
26(9):4100-4104.
PMID: 38860411
No abstract available.
3.
Tinti D, Canavese C, Nobili C, Marcotulli D, Daniele E, Rabbone I, et al.
Front Med (Lausanne)
. 2024 May;
11:1331145.
PMID: 38784238
Aims: Diabetic neuropathy (DN) is one of the most insidious microvascular complications in patients with type 1 diabetes (T1DM) and initial signs may appear during childhood. The aim of this...
4.
Cherubini V, Fargalli A, Arnaldi C, Bassi M, Bonfanti R, Patrizia Bracciolini G, et al.
Diabetes Res Clin Pract
. 2024 Mar;
210:111621.
PMID: 38499182
Aims: To analyze metabolic outcomes, diabetes impact and device satisfaction in children and adolescents with type 1 diabetes in Italy who used different treatment modalities for diabetes care in a...
5.
Rapini N, Delvecchio M, Mucciolo M, Ruta R, Rabbone I, Cherubini V, et al.
J Clin Endocrinol Metab
. 2024 Feb;
109(9):2349-2357.
PMID: 38408297
Context: In the last decade the Sanger method of DNA sequencing has been replaced by next-generation sequencing (NGS). NGS is valuable in conditions characterized by high genetic heterogeneity such as...
6.
Catamo E, Tornese G, Dovc K, Tinti D, Di Tonno R, Cauvin V, et al.
Foods
. 2024 Feb;
13(4).
PMID: 38397555
Diet is an essential element of treating and managing type 1 diabetes (T1D). However, limited research has examined food behaviour in children and adolescents with T1D and their relationship to...
7.
Franceschi R, Pertile R, Marigliano M, Mozzillo E, Maffeis C, Morotti E, et al.
Diabet Med
. 2024 Feb;
41(6):e15307.
PMID: 38383984
Aims: While continuous glucose monitoring (CGM) and associated technologies have positive effects on metabolic control in young people with type 1 diabetes (T1D), less is known about their impact on...
8.
Marigliano M, Pertile R, Mozzillo E, Troncone A, Maffeis C, Morotti E, et al.
Diabetes Res Clin Pract
. 2023 Sep;
204:110895.
PMID: 37673191
Aims: Continuous glucose monitoring (CGM) can improve glucometrics in children with type 1 diabetes (T1D), and its efficacy is positively related to glucose sensor use for at least 60% of...
9.
Robino A, Tornese G, Tinti D, Dovc K, Castorani V, Conti A, et al.
Biomedicines
. 2023 Jul;
11(7).
PMID: 37509590
The HNF1A transcription factor, implicated in the regulation of pancreatic beta cells, as well as in glucose and lipid metabolism, is responsible for type 3 maturity-onset diabetes of the young...
10.
Catamo E, Robino A, Dovc K, Tinti D, Tamaro G, Bonfanti R, et al.
Front Endocrinol (Lausanne)
. 2023 Jun;
14:1186913.
PMID: 37334303
Introduction: The purpose of this study was to evaluate lipid profile and kidney function in children and adolescents with Type 1 Diabetes. Methods: This was a retrospective study including 324...